VANI Director/10% owner reports two stock purchases at $1.12 and $1.26

Rhea-AI Filing Summary

Vivani Medical (VANI) insider filed a Form 4 reporting open-market style private purchases. On 10/15/2025, the reporting person, a Director and 10% Owner, acquired 1,473,214 shares at $1.12 per share pursuant to a Share Purchase Agreement dated March 26, 2025, and 264,550 shares at $1.26 per share pursuant to a Share Purchase Agreement dated August 11, 2025.

Following these transactions, beneficial ownership stood at 17,647,112 shares held indirectly and 4,799,200 shares held directly, for a combined 22,446,312 shares with voting and dispositive power over all such shares.

Insights

Equity Ownership and Governance Analyst

Director/10% owner increased stake via private purchases; higher ownership concentration and disclosed voting control.

The reporting person, a **Director and 10% Owner** of **Vivani Medical, Inc. (VANI)**, acquired a total of 1,737,764 common shares on 10/15/2025 through two private sale transactions tied to Share Purchase Agreements dated March 26, 2025 and August 11, 2025. The purchases were at $1.12 for 1,473,214 shares and $1.26 for 264,550 shares, with disclosed gross proceeds of $1,649,999.68 and $333,333.00, respectively.

Following these transactions, the filer reports beneficial ownership of **22,446,312** shares, composed of **4,799,200** direct and **17,647,112** indirect, held across specified entities. The filing states **Gregg Williams** has voting and dispositive power over all these shares. This reflects meaningful ownership concentration, which can influence governance outcomes such as board matters and shareholder votes.

Key items to watch include any subsequent Forms 4 showing additional acquisitions or dispositions, and future filings that may reference these Share Purchase Agreements. The reported dates and amounts provide clear markers: execution on 10/15/2025 and aggregate post-transaction holdings of 22.45 million shares. Any change in voting power disclosure or entity breakdown in later filings would be notable.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Williams Gregg

(Last) (First) (Middle)

C/O VIVANI MEDICAL, INC.

1350 S. LOOP ROAD

(Street)

ALAMEDA CA 94502

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vivani Medical, Inc. [ VANI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/15/2025		P(1)		1,473,214	A	$1.12	17,382,562	I	See footnote(3)
Common Stock	10/15/2025		P(2)		264,550	A	$1.26	17,647,112	I	See footnote(3)
Common Stock								4,799,200	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person purchased 1,473,214 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of March 26, 2025 at a price of $1.12 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on March 25, 2025 (the day immediately prior to March 26, 2025). The gross proceeds from this private sale transaction were $1,649,999.68. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.

2. The reporting person purchased 264,550 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025 at a price of $1.26 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on August 10, 2025 (the day immediately prior to August 11, 2025). The gross proceeds from this private sale transaction were $333,333.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.

3. The reporting person owns 22,446,312 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 15,521,360 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

	/s/ Anthony Baldor, Attorney-in-fact	10/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions were reported for VANI?

A Director and 10% Owner reported buying 1,473,214 shares at $1.12 and 264,550 shares at $1.26 on 10/15/2025.

What were the purchase prices disclosed in the VANI Form 4?

The purchases were at $1.12 per share and $1.26 per share.

How many VANI shares does the reporting person now beneficially own?

After the transactions, the reporting person beneficially owns 22,446,312 shares.

How are the VANI shares held by the reporting person categorized?

The filing shows 17,647,112 shares held indirectly and 4,799,200 shares held directly.

What agreements are tied to the VANI share purchases?

The purchases were disclosed in Share Purchase Agreements dated March 26, 2025 and August 11, 2025.

Who has voting and dispositive power over the reported VANI shares?

The filing states the reporting person has voting and dispositive power over all such shares.